← Back to All US Stocks

Elutia Inc.. (ELUT) Stock Fundamental Analysis & AI Rating 2026

ELUT Nasdaq Biological Products, (No Diagnostic Substances) DE CIK: 0001708527
Updated This Month • Analysis: Mar 24, 2026 • SEC Data: 2025-12-31
Combined AI Rating
SELL
88% Confidence
AGREEMENT
SELL
85% Conf
STRONG SELL
91% Conf

📊 ELUT Key Takeaways

Revenue: $12.3M
Net Margin: 434.2%
Free Cash Flow: $-46.7M
Current Ratio: 2.22x
Debt/Equity: 0.94x
EPS: $0.87
AI Rating: SELL with 85% confidence
Elutia Inc.. (ELUT) receives a SELL rating with 88% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $12.3M, net profit margin of 434.2%, and return on equity (ROE) of 192.9%, Elutia Inc.. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete ELUT stock analysis for 2026.

Is Elutia Inc.. (ELUT) a Good Investment?

Claude

Elutia exhibits severe operational dysfunction with massive operating losses (-218.9% margin) despite modest revenue of $12.3M, which declined 15% YoY. The extraordinary net income of $53.4M appears driven by non-operating gains (likely asset sales or accounting adjustments) rather than core business performance, masking deteriorating fundamentals. Negative free cash flow of -$46.7M combined with $26.1M long-term debt and rapidly depleting cash reserves signal an unsustainable burn rate.

ChatGPT

Elutia's core fundamentals are weak: revenue declined 15% year over year, operating margin was deeply negative at -218.9%, and free cash flow was severely negative, indicating poor growth quality and an unsustainable earnings profile. The large net income appears disconnected from operating performance, suggesting a likely non-recurring benefit rather than a true improvement in the underlying business. While liquidity is currently supported by a solid cash balance and acceptable current ratio, persistent operating losses and cash burn materially weaken financial health.

Why Buy Elutia Inc.. Stock? ELUT Key Strengths

Claude
  • + Strong liquidity position with $36.4M cash and 2.22x current ratio provides near-term runway
  • + High gross margin of 53.7% indicates viable product economics at the unit level
  • + Moderate leverage ratio of 0.94x debt-to-equity provides some balance sheet cushion
ChatGPT
  • + Gross margin of 53.7% suggests the company still has some underlying product-level economic value
  • + Cash and equivalents of $36.35M provide near-term liquidity support
  • + Current ratio of 2.22x and quick ratio of 2.12x indicate manageable short-term obligations

ELUT Stock Risks: Elutia Inc.. Investment Risks

Claude
  • ! Severe cash burn of $46.7M free cash flow with only 10+ quarters of runway at current burn rate
  • ! Revenue contraction of 15% YoY combined with -218.9% operating margin indicates business is not scaling profitably
  • ! Negative interest coverage of -20.5x indicates inability to service debt from operating earnings; dependent on non-recurring gains
  • ! Operating cash flow of -$44.8M signals core business is destroying rather than generating cash
  • ! Net margin of 434.2% is unrealistic and driven by one-time items, masking true operational performance
ChatGPT
  • ! Revenue fell 15.0% year over year, pointing to weak commercial momentum
  • ! Operating loss of $26.91M and free cash flow of -$46.69M indicate severe cash burn and poor earnings quality
  • ! Leverage is meaningful relative to equity, and negative interest coverage reflects weak debt-servicing capacity from operations

Key Metrics to Watch

Claude
  • * Operating cash flow trend and path to cash flow breakeven
  • * Revenue growth trajectory and customer acquisition/retention rates
  • * Operating margin improvement and achievement of sustainable profitability
  • * Cash runway and timeline to additional capital needs
  • * Composition of net income gains to assess recurrence of reported profits
ChatGPT
  • * Revenue growth and gross profit trend
  • * Operating cash flow and free cash flow burn rate

Elutia Inc.. (ELUT) Financial Metrics & Key Ratios

Revenue
$12.3M
Net Income
$53.4M
EPS (Diluted)
$0.87
Free Cash Flow
$-46.7M
Total Assets
$62.4M
Cash Position
$36.4M

💡 AI Analyst Insight

Strong liquidity with a 2.22x current ratio provides a solid financial cushion.

ELUT Profit Margin, ROE & Profitability Analysis

Gross Margin 53.7%
Operating Margin -218.9%
Net Margin 434.2%
ROE 192.9%
ROA 85.6%
FCF Margin -379.8%

ELUT vs Healthcare Sector: How Elutia Inc.. Compares

How Elutia Inc.. compares to Healthcare sector averages

Net Margin
ELUT 434.2%
vs
Sector Avg 12.0%
ELUT Sector
ROE
ELUT 192.9%
vs
Sector Avg 15.0%
ELUT Sector
Current Ratio
ELUT 2.2x
vs
Sector Avg 2.0x
ELUT Sector
Debt/Equity
ELUT 0.9x
vs
Sector Avg 0.6x
ELUT Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Elutia Inc.. Stock Overvalued? ELUT Valuation Analysis 2026

Based on fundamental analysis, Elutia Inc.. appears fundamentally strong relative to the Healthcare sector in 2026.

Return on Equity
192.9%
Sector avg: 15%
Net Profit Margin
434.2%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.94x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Elutia Inc.. Balance Sheet: ELUT Debt, Cash & Liquidity

Current Ratio
2.22x
Quick Ratio
2.12x
Debt/Equity
0.94x
Debt/Assets
55.6%
Interest Coverage
-20.50x
Long-term Debt
$26.1M

ELUT Revenue & Earnings Growth: 5-Year Financial Trend

ELUT 5-year financial data: Year 2021: Revenue $47.4M, Net Income -$21.8M, EPS $-8.88. Year 2022: Revenue $49.2M, Net Income -$24.8M, EPS $-2.38. Year 2023: Revenue $24.7M, Net Income -$32.9M, EPS $-2.38. Year 2024: Revenue $24.7M, Net Income -$37.7M, EPS $-2.07. Year 2025: Revenue $14.5M, Net Income -$53.9M, EPS $-1.86.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Elutia Inc..'s revenue has declined by 69% over the 5-year period, indicating business contraction. The most recent EPS of $-1.86 indicates the company is currently unprofitable.

ELUT Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-379.8%
Free cash flow / Revenue

ELUT Quarterly Earnings & Performance

Quarterly financial performance data for Elutia Inc.. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $3.3M $1.3M $-0.19
Q2 2025 $6.3M -$9.6M $-0.26
Q1 2025 $6.0M -$3.9M $-0.21
Q3 2024 $5.9M $1.3M $-0.33
Q2 2024 $6.3M -$10.6M $-0.65
Q3 2023 $5.8M -$8.0M $-0.49
Q2 2023 $10.3M -$9.4M $-0.65
Q1 2023 $11.5M -$8.0M $-0.49

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Elutia Inc.. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$44.8M
Cash generated from operations
Capital Expenditures
$1.9M
Investment in assets
Dividends
None
No dividend program

ELUT SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Elutia Inc.. (CIK: 0001708527)

📋 Recent SEC Filings

Date Form Document Action
Apr 14, 2026 4 xslF345X06/form4-04142026_120452.xml View →
Mar 13, 2026 10-K elut-20251231x10k.htm View →
Mar 12, 2026 4 xslF345X05/form4-03122026_050310.xml View →
Mar 12, 2026 4 xslF345X05/form4-03122026_050308.xml View →
Mar 12, 2026 4 xslF345X05/form4-03122026_050305.xml View →

Frequently Asked Questions about ELUT

What is the AI rating for ELUT?

Elutia Inc.. (ELUT) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (STRONG SELL) with 88% combined confidence, based on fundamental analysis of SEC EDGAR filings.

What are ELUT's key strengths?

Claude: Strong liquidity position with $36.4M cash and 2.22x current ratio provides near-term runway. High gross margin of 53.7% indicates viable product economics at the unit level. ChatGPT: Gross margin of 53.7% suggests the company still has some underlying product-level economic value. Cash and equivalents of $36.35M provide near-term liquidity support.

What are the risks of investing in ELUT?

Claude: Severe cash burn of $46.7M free cash flow with only 10+ quarters of runway at current burn rate. Revenue contraction of 15% YoY combined with -218.9% operating margin indicates business is not scaling profitably. ChatGPT: Revenue fell 15.0% year over year, pointing to weak commercial momentum. Operating loss of $26.91M and free cash flow of -$46.69M indicate severe cash burn and poor earnings quality.

What is ELUT's revenue and growth?

Elutia Inc.. reported revenue of $12.3M.

Does ELUT pay dividends?

Elutia Inc.. does not currently pay dividends.

Where can I find ELUT SEC filings?

Official SEC filings for Elutia Inc.. (CIK: 0001708527) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is ELUT's EPS?

Elutia Inc.. has a diluted EPS of $0.87.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is ELUT a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Elutia Inc.. has a SELL rating with 88% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is ELUT stock overvalued or undervalued?

Valuation metrics for ELUT: ROE of 192.9% (sector avg: 15%), net margin of 434.2% (sector avg: 12%). Higher ROE suggests strong returns relative to peers.

Should I buy ELUT stock in 2026?

Our dual AI analysis gives Elutia Inc.. a combined SELL rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.

What is ELUT's free cash flow?

Elutia Inc..'s operating cash flow is $-44.8M, with capital expenditures of $1.9M. FCF margin is -379.8%.

How does ELUT compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin 434.2% (avg: 12%), ROE 192.9% (avg: 15%), current ratio 2.22 (avg: 2).

Why is ELUT's return on equity (ROE) so high?

Elutia Inc.. has a return on equity of 192.9%, significantly above the Healthcare sector average of 15%. A high ROE indicates the company is efficient at generating profits from shareholder equity. This is supported by a 434.2% net margin.

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Sector: All Healthcare Stocks →
Browse: High ROE Stocks
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 24, 2026 | Data as of: 2025-12-31 | Powered by Claude AI